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Response to Comment on
“Human-Specific Gain of Function
in a Developmental Enhancer”
Shyam Prabhakar,1* Axel Visel,1 Jennifer A. Akiyama,1 Malak Shoukry,1 Keith D. Lewis,1†
Amy Holt,1 Ingrid Plajzer-Frick,1 Harris Morrison,2 David R. FitzPatrick,2 Veena Afzal,1
Len A. Pennacchio,1,3 Edward M. Rubin,1,3‡ James P. Noonan1‡§
Duret and Galtier argue that human-specific sequence divergence and gain of function in the
HACNS1 enhancer result from deleterious biased gene conversion (BGC) with no contribution
from positive selection. We reinforce our previous conclusion by analyzing hypothesized BGC
events genomewide and assessing the effect of recombination rates on human-accelerated
conserved noncoding sequence ascertainment. We also provide evidence that AT → GC substitution
bias can coexist with positive selection.
Duret and Galtier (1) suggest that biasedgene conversion (BGC) alone drovethe rapid human-specific evolution of
human-accelerated conserved noncoding se-
quence 1 (HACNS1) (2, 3) and that positive se-
lection played no role. BGC is a nonadaptive,
recombination-driven mechanism hypothesized
to increase the rate of AT→ GC substitutions in
a given interval (4, 5). In support, it has been
shown that the AT → GC substitution rate is
more strongly correlated with male recombina-
tion rate than with GC content (6). Clusters [100
to 1000 base pairs (bp)] of human-specific sub-
stitutions occurring in regions of elevated male
recombination rate show an AT → GC bias,
which suggests that BGC may have contributed
to some substitution hotspots in the genome (5).
These correlations are stronger at the 1 Mb scale
than at finer scales, likely because fine-scale re-
combination rates are less stable over time than
coarse-scale rates (5, 7, 8). In addition, human-
accelerated regions (HARs) identified in a whole-
genome screen of conserved genomic elements
have an excess of AT→ GC substitutions and are
enriched in broad regions of high average recom-
bination (4, 9, 10).
In light of these findings, Duret and Galtier's
observation that some HARs and HACNSs could
be due solely to BGC is reasonable (4). However,
their present attempt to extrapolate this argument
to HACNS1 requires several unsupported assump-
tions regarding the ascertainment of HACNSs
compared with HARs and the known distribution
of recombination hotspots in the genome. We
examine the authors’ claims below.
The robust gain of limb expression inHACNS1
is not in itself evidence of adaptation. However,
the most likely effect of deleterious substitution
in the enhancer would be to randomly distort the
existing function rather than to strengthen the an-
cestral expression pattern while introducing a new,
robust expression domain. The precise, highly
spatially restricted gain of function in HACNS1
is exactly what one would expect from an adapt-
ive process that altered a specific functional mod-
ule in the enhancer, as suggested by the pattern
of substitutions we observed, while leaving the an-
cestral expression domains intact. Therefore, we
find the adaptive hypothesis qualitatively more
parsimonious than the authors’ alternative (1).
Overrepresentation of HARs in subtelomeric
regions, which display high recombination rates,
has been cited as evidence that some HARs are
due to BGC rather than to positive selection (4, 10).
However, in assuming that HACNSs suffer from
a similar systematic bias, Duret and Galtier mis-
understand how HACNSs were identified. In con-
trast to HARs, which were ascertained relative
to whole-genome averaged substitution rates,
HACNSs were defined based on their acceler-
ation relative to the local neutral substitution
rate (2, 9). Thus, the method used to identify
HACNSs mitigates the local average effect of
recombination-driven BGC on substitution rates.
Although some HACNSs may be due to BGC, a
comparison of HACNS distribution relative to
male-specific recombination rates demonstrates
that HACNSs as a class show no enrichment in
regions of high recombination (Table 1) (11).
Moreover, the fraction of conserved noncoding
sequences within a 10-Mb window centered on
HACNS1 that are HACNSs (0.8%) is lower than
the whole-genome average (0.9%). The elevated
male-specific recombination rate around HACNS1
thus has no bearing on whether HACNS1 is af-
fected by BGC.
Because HACNSs show no correlation with
coarse-scale recombination rates, Duret and Galtier's
claim that BGC explains human-specific accel-
eration in HACNS1 rests on a single point: the
excess of AT→ GC substitutions in the enhancer.
As we discussed in (3), this AT→ GC excess is
not confined to the 546-bp HACNS1 element; in-
stead, it extends into the nonconserved flanking
regions, covering ~5 kb in all (3). However, the
overall human-specific substitution rate is close
to the local (1 Mb) average rate across nearly
this entire region, with one critical exception: the
sharp spike of 13 substitutions in a highly con-
strained 81-bp subregion within HACNS1.
Duret and Galtier (1) propose a nonparsimo-
nious “BGC only” scenario for the spatial pro-
file of substitutions in and around HACNS1: a
sharp (~80 bp), extremely strong recombination
hotspot embedded in a larger (~5 kb) weak hot-
spot. In support, they claim that such a spatial
profile is “in agreement with current knowledge
about the spatiotemporal distribution of recom-
bination in humans” and reference Myers et al.
(12). However, this is a misinterpretation, because
that study analyzed recombination rates at a low
resolution of ~2 kb and therefore cannot provide
insight on the likelihood of ~80-bp hotspots within
larger “warmspots.” Moreover, the authors’ pro-
posed BGC-driven cluster of 13 substitutions in
81 bp is implausibly narrow and dense, even when
compared with the 200 most extreme putative
BGC-driven substitution hotspots in the genome,
which average ~370 bp and have an average sub-
stitution density equivalent to <5 substitutions in
81 bp (5).
We reject the authors’ assumption that BGC
and adaptation are mutually exclusive. The high-
ly localized spike in the substitution rate inHACNS1
is more consistent with positive selection than
with BGC. However, the AT→ GC substitution
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Table 1. Lack of HACNS enrichment in regions of high male-specific recombination (11).
All CNSs HACNSs Fishertwo-sided P
Total in genome 110,549 992
No. in regions with
male recomb ≥2.0 cM
13,542
(12.3%)
135
(13.6%)
0.25
No. in regions with
male recomb ≥2.5 cM
9,330
(8.44%)
87
(8.77%)
0.73
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bias in the rapidly evolving segment of HACNS1
and in the ~5-kb flanking sequence where the
overall substitution rate is not elevated suggests
that BGC may have influenced the evolution of
this enhancer. The substitution pattern in HACNS1
may thus be due to positive selection synergiz-
ing with a moderate BGC domain. A recombi-
nation hotspot of mild strength, that extended
over ~5 kb and elevated the fraction of AT→ GC
substitutions without increasing the overall sub-
stitution rate, would explain the observed substi-
tution pattern in the neutral sequence surrounding
HACNS1. Within HACNS1, positive selection for
new GC-rich transcription factor binding sites or
loss of AT-rich sites likely amplified a modest
AT→ GC fixation bias caused by BGC, produc-
ing a sharp increase in the substitution rate with-
in an ~80 bp cluster of binding sites that generated
the human-specific gain of limb expression.
Evidence that an extreme AT→ GC substitu-
tion bias can coexist with positive selection comes
from a 382-bp putative BGC event (chr18:897,475-
897,857 in hg18) identified by Dreszer et al. (5),
which contains 19 substitutions and overlaps
exon 2 of ADCYAP1. In parallel to HACNS1, the
human-specific substitutions comprising this BGC
event are significantly clustered in functional se-
quence: The 132-bp exon contains 13/19 substi-
tutions (Fisher’s exact test, P = 0.002), despite
being conserved across terrestrial vertebrate ge-
nomes. All 13 substitutions are AT → GC and
produce 11 amino acid changes. The human-
specific nonsynonymous substitution rate in the
exon is well above the synonymous rate (dN/dS =
3.2), a classic signature of adaptive evolution (13).
It is difficult to imagine how neutral or deleteri-
ous BGC could selectively favor nonsynonymous
substitutions. We hypothesize that accelerated
evolution inADCYAP1 andHACNS1 are due to a
commonmechanism: synergy between BGC and
positive selection producing a cluster of AT→GC
substitutions at functional sites.
In summary, we find no basis for the authors’
claim that the gain of function in HACNS1 is
solely due to BGC. Our analysis reinforces our
initial conclusion, that positive selection likely
played a role in HACNS1 evolution.
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